Finally, we present future perspectives on how the integration of longitudinal omics, computational modeling, and innovative clinical trial designs may reshape the therapeutic landscape and improve long-term outcomes for patients with drug-resistant malignancies
Now a new study in Nature Communications finds a 50-56% decrease in the risk of new or recurring alcohol addictions for people taking semaglutide for obesity or diabetes
Srikant M, Van Veen J, Raithatha A, Reilly JT
While GLP-1 medication helps regulate appetite, healthy lifestyle habits remain vital
Patients taking multiple medications need providers who can identify and manage drug interactions
Freezing voids the stability claims provided by your licensed 503A compounding pharmacy and may render your medication unsafe or ineffective